Equities Analysts Offer Predictions for ACTU Q1 Earnings
Actuate Therapeutics (NASDAQ:ACTU – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Actuate Therapeutics in a research note issued on Monday, March 17th. HC Wainwright analyst S. Ramakanth expects that the company will earn ($0.26) per share for the quarter. HC Wainwright has a “Buy” rating […]
Actuate Therapeutics (NASDAQ:ACTU – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Actuate Therapeutics in a research note issued on Monday, March 17th. HC Wainwright analyst S. Ramakanth expects that the company will earn ($0.26) per share for the quarter. HC Wainwright has a “Buy” rating […]
